HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Vacc-4x

immunotherapy candidate composed of four modified peptides corresponding to conserved domains of the HIV-1 protein p24 that preferentially include HLA-A2 restricted elements
Networked: 6 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Sørensen, Birger: 5 articles (09/2013 - 09/2004)
2. Kvale, Dag: 5 articles (09/2013 - 09/2004)
3. Baksaas, Ingebjørg: 4 articles (09/2013 - 09/2004)
4. Sommerfelt, Maja A: 3 articles (11/2010 - 09/2004)
5. Kran, Anne-Marte B: 3 articles (11/2010 - 09/2004)
6. Sommerfelt, Maja: 2 articles (09/2013 - 08/2012)
7. Lind, Andreas: 2 articles (09/2013 - 08/2012)
8. Nyhus, Jørgen: 2 articles (07/2005 - 09/2004)
9. Bruun, Johan N: 2 articles (07/2005 - 09/2004)
10. Holmberg, Jens O: 1 article (09/2013)

Related Diseases

1. Hypersensitivity (Allergy)
2. HIV Infections (HIV Infection)
3. Viremia
4. Acquired Immunodeficiency Syndrome (AIDS)

Related Drugs and Biologics

1. RNA (Ribonucleic Acid)
2. Peptides
3. Granzymes (Granzyme)
4. Chemokines
5. Cytokines
6. 5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)

Related Therapies and Procedures

1. Highly Active Antiretroviral Therapy (HAART)